| Zdroj: |
Hallas, J, Margulis, A V, Pottegård, A, Kaye, J A, Kristiansen, N S, Bui, C L, Atsma, W J, Appenteng, K, Franks, B, de Vogel, S, D’Silva, M, Perez-Gutthann, S & Arana, A 2016, ' Elevated Bladder and Prostate Cancer Rates Following Initiation of OAB Medication : Findings From the Danish Registries, 2004-2012 ', 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Dublin, Ireland, 25/08/2016-28/08/2016 . < https://www.rtihs.org/sites/default/files/27479%20Margulis%202016%20Elevated%20bladder%20and%20prostate%20cancer%20rates%20following%20initiation%20of%20OAB%20medication.pdf > |
